Thursday, June 30, 2022

561.316.3330

Croma Aesthetics Canada Launches saypha® VOLUME PLUS

Latest Posts

Kyowa Kirin Expands License Agreement with Synaffix and Takes Exclusive Target Rights Based on Latest Positive ADC Data

The technology licensed from Synaffix include GlycoConnect™, HydraSpace™, and multiple toxSYN™ linker-payloads, which allow for the drug-to-antibody ratio (DAR) to be tailored to 1, 2 or 4 to optimize the therapeutic index of the ADC.

Ingenza Awarded Government Funding

Ingenza advises the project aims to develop a novel CO2 conversion technology, which will capture industrial CO2 emissions and convert them into formate, a versatile chemical that can be used across various industries, including pharmaceuticals and agriculture.

MultiOmic Health and Mesh Bio Partner to Use AI to Develop Precision Medicines & Diagnostics for Chronic Metabolic Disease

MultiOmic Health advises the partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic disease studies.

BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus

BD notes the test uses a single nasal swab or a single nasopharyngeal swab sample to determine if a patient has COVID-19 or the flu or RSV. It helps eliminate the need for multiple tests or doctor visits and can help clinicians to implement the right treatment plan quickly.

Croma Aesthetics Canada Ltd., doing business as Hugel Aesthetics is pleased to announce the launch of saypha® VOLUME PLUS, a hyaluronic acid dermal filler product specifically designed to restore facial volume.1

The launch of saypha® VOLUME PLUS into the Canadian market will enhance the available line of saypha® dermal fillers, giving aesthetic medical professionals more creative power to design a truly bespoke experience for their patients.

saypha® VOLUME PLUS launches at a time when the aesthetic injectables market is on the fast track to growth thanks to emerging Aesthetic Next consumer segments including men and millennials.2 With this launch, Hugel Aesthetics aims to appeal to a broader and more youthful consumer demographic than current fillers on the market. The associated marketing campaign for saypha® VOLUME PLUS is designed to specifically capture the needs and wants of this Aesthetic Next generation by redesigning the filler experience from discovery to purchase.

“What constitutes luxury today takes on a modern, new meaning with our target consumer. For them, luxury is about an affordable, authentic, and transparent experience with a quality product that makes them feel special,” said Bob Bennett, GM of Hugel Aesthetics. “At Hugel Aesthetics we are committed to tailoring and elevating the consumer’s experience with our brands in ways that surprise and delight, and the launch of the saypha® VOLUME PLUS product is just the beginning for us.”

saypha® products are available throughout Canada. Providers are encouraged to contact their Evolve Medical Representative or email cscanada@hugel-aesthetics.com for product and ordering information.

About saypha®

The Croma HA filler range available in Canada consists of three products: saypha® FILLER Lidocaine, saypha® VOLUME Lidocaine and saypha® VOLUME PLUS.

The products target individual needs of the patients:

saypha® FILLER Lidocaine is indicated to correct light to moderate nasolabial folds. The product is injected into the mid to deep dermis.3

saypha® VOLUME Lidocaine is indicated for the correction of deeper wrinkles in the nasolabial folds. The product is injected into a deeper skin layer (deep dermis).4

saypha® VOLUME PLUS is indicated to correct moderate to severe midface volume deficit in the zygomaticomalar region, anteromedial cheek region and submalar region. The product is injected deep subcutaneously or supraperiosteally. 1

All products are based on non-animal derived hyaluronic acid and are manufactured in accordance with the highest safety and quality standards.

As with any medical procedure, there is always a risk of unwanted side effects with HA facial filler treatments. Patients should speak with their doctor about the benefits and risk of any procedure.

The saypha® range of fillers should only be administered by a trained and qualified medical aesthetics healthcare practitioner.


References

1. saypha® VOLUME PLUS Lidocaine Instructions for Use

2. Leclerc, O., Peters, N., Scaglione, A., Waring,J. (2021, December 21). From extreme to mainstream: The future of aesthetics injectables. McKinsey &Company. https://www.mckinsey.com/industries/life-sciences/our-insights/from-extreme-to-mainstream-the-future-of-aesthetics-injectables

3. saypha® FILLER Lidocaine Instructions for Use

4. saypha® VOLUME Lidocaine Instructions for Use

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine